Strong muscles, weak heart: testosterone‐induced cardiomyopathy
Abstract Exogenous anabolic androgen steroid use is associated with adverse cardiovascular outcomes. A 53‐year‐old bodybuilder presented with 3 months of exertional dyspnoea. Physical examination showed tachycardia and pan‐systolic murmur; an echocardiogram showed a left ventricular ejection fractio...
Main Authors: | Sarah Doleeb, Ann Kratz, Monica Salter, Vinay Thohan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-10-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.12494 |
Similar Items
-
Combined effects of growth hormone and testosterone replacement treatment in heart failure
by: Andrea Salzano, et al.
Published: (2019-12-01) -
Testosterone treatment in chronic heart failure. Review of literature and future perspectives
by: Roberta D'Assante, et al.
Published: (2018-09-01) -
Acute response to endurance exercise stress: Focus on catabolic/anabolic interplay between cortisol, testosterone, and sex hormone binding globulin in professional athletes
by: Popović Bojana, et al.
Published: (2019-01-01) -
Effects of short-term betaine supplementation on muscle endurance and indices of endocrine function following acute high-intensity resistance exercise in young athletes
by: Hamid Arazi, et al.
Published: (2022-12-01) -
Profiling of Metabolomic Changes in Plasma and Urine of Pigs Caused by Illegal Administration of Testosterone Esters
by: Kamil Stastny, et al.
Published: (2020-07-01)